Gene: DEGS2
Official Full Name: delta 4-desaturase, sphingolipid 2provided by HGNC
Gene Summary: This gene encodes a bifunctional enzyme that is involved in the biosynthesis of phytosphingolipids in human skin and in other phytosphingolipid-containing tissues. This enzyme can act as a sphingolipid delta(4)-desaturase, and also as a sphingolipid C4-hydroxylase. [provided by RefSeq, Oct 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07661 | DEGS2 Knockout cell line (HEK293) | Human | DEGS2 | 1:3~1:6 | Negative | Online Inquiry |
KO07662 | DEGS2 Knockout cell line (A549) | Human | DEGS2 | 1:3~1:4 | Negative | Online Inquiry |
DEGS2 Gene Knockout Cell Lines are engineered cellular models created to study the specific functions and pathways of the DEGS2 gene, which encodes a critical enzyme involved in sphingolipid metabolism. This knockout approach enables researchers to investigate the regulatory mechanisms and physiological roles of DEGS2 by providing a loss-of-function context. The cell lines are produced using CRISPR-Cas9 technology, which allows for precise editing of the genome to eliminate DEGS2 expression.
DEGS2 plays a vital role in the synthesis of sphingosine, a lipid involved in various biological processes, such as cell proliferation, apoptosis, and signaling pathways. By utilizing these knockout cell lines, scientists can elucidate the impact of DEGS2 deficiency on cellular behaviors and lipid metabolism, ultimately contributing to our understanding of conditions such as metabolic disorders, neurodegenerative diseases, and cancer. The ability to analyze these cellular responses in a controlled environment makes these knockout lines an invaluable resource for both basic and translational research.
One of the significant advantages of DEGS2 Gene Knockout Cell Lines is the specificity of the genetic modification, which minimizes off-target effects commonly associated with other gene-editing techniques. Compared to alternative models, such as transient transfection systems, these stable knockout lines provide consistent and reproducible results across experiments, ensuring reliable data for hypothesis testing.
For researchers and clinicians, the DEGS2 Gene Knockout Cell Lines represent a powerful tool for unraveling the complexities of lipid metabolism and its implications in health and disease. The insight gained from these studies may lead to improved therapeutic strategies targeting lipid dysregulation.
Our company prides itself on delivering high-quality, validated biological products that empower scientific inquiry and innovation. With a focus on cutting-edge gene editing technologies and a commitment to precision, we ensure that our DEGS2 Gene Knockout Cell Lines meet the highest standards for research excellence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.